Gaois

Search direction

Search mode

Filter results

Collections

7 results in 6 documents

  1. #1798467

    Déanfar an méid tiomanta de shaoráid leachtachta atá curtha ar fáil don SSPE chun cur ar chumas an SSPE sin sócmhainní a cheannach, seachas urrúis, ó chliaint nach custaiméirí airgeadais iad, a iolrú faoi 10 % ar an gcoinníoll go sáraíonn an méid tiomanta méid na sócmhainní atá ceannaithe cheana féin ó chliaint agus go mbeidh an t-uasmhéid is féidir a tharraingt teoranta go conarthach do mhéid na sócmhainní atá ceannaithe cheana féin.”;

    The committed amount of a liquidity facility that has been provided to an SSPE for the purpose of enabling that SSPE to purchase assets, other than securities, from clients that are not financial customers shall be multiplied by 10 %, provided that the committed amount exceeds the amount of assets currently purchased from clients and that the maximum amount that can be drawn is contractually limited to the amount of assets currently purchased.’;

    Regulation (EU) 2019/876 of the European Parliament and of the Council of 20 May 2019 amending Regulation (EU) No 575/2013 as regards the leverage ratio, the net stable funding ratio, requirements for own funds and eligible liabilities, counterparty credit risk, market risk, exposures to central counterparties, exposures to collective investment undertakings, large exposures, reporting and disclosure requirements, and Regulation (EU) No 648/2012 (Text with EEA relevance.)

  2. #2486666

    Tionscnóirí a úsáideann cur chuige bunaithe ar rátálacha inmheánacha - An méid iomlán a ghealltar in aghaidh na bliana nach airde é ná méideanna an chaillteanais ionchasaigh rialála aon bhliana

    Originators using Internal-Ratings-Based approach – Total committed amount per year not higher than the one-year regulatory expected loss amounts

    Commission Delegated Regulation (EU) 2022/1301 of 31 March 2022 amending the regulatory technical standards laid down in Delegated Regulation (EU) 2020/1226 as regards the information to be provided in accordance with the STS notification requirements for on-balance-sheet synthetic securitisations

  3. #2530445

    Tionscnóirí a úsáideann cur chuige bunaithe ar rátálacha inmheánacha — An méid iomlán a ghealltar in aghaidh na bliana gan a bheith níos mó ná méideanna an chaillteanais ionchasaigh rialála 1 bhliana

    Originators using Internal-Ratings-Based approach – Total committed amount per year not higher than the one-year regulatory expected loss amounts

    Commission Implementing Regulation (EU) 2022/1929 of 31 March 2022 amending the implementing technical standards laid down in Implementing Regulation (EU) 2020/1227 as regards the templates for the provision of information in accordance with the STS notification requirements for on-balance-sheet synthetic securitisations

  4. #589438

    Déanfar an méid tiomanta de shaoráid leachtachta atá curtha ar fáil do SSPE d'fhonn cur ar chumas SSPE sin sócmhainní a cheannach, seachas urrúis, ó chliaint nach custaiméirí airgeadais iad, a iolrú faoi 10 % a mhéid a sháraíonn sé méid na sócmhainní atá ceannaithe cheana féin ó chliaint agus áit a mbeidh an t-uasmhéid is féidir a tharraingt teoranta go conarthach do mhéid na sócmhainní atá ceannaithe cheana féin.

    The committed amount of a liquidity facility that has been provided to an SSPE for the purpose of enabling such an SSPE to purchase assets other than securities from clients that are not financial customers shall be multiplied by 10 % to the extent that it exceeds the amount of assets currently purchased from clients and where the maximum amount that can be drawn is contractually limited to the amount of assets currently purchased.

    Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 Text with EEA relevance

  5. #2011838

    maidir le tionscnóirí a bhaineann úsáid as Cur Chuige IRB dá dtagraítear in Airteagal 143 de Rialachán (AE) Uimh. 575/2013, ní bheidh an méid iomlán a ghealltar in aghaidh na bliana níos airde ná suimeanna rialála na gcaillteanas ionchasach 1 bhliana amháin ar na neamhchosaintí foluiteacha uile le haghaidh na bliana sin, arna ríomh i gcomhréir le hAirteagal 158 den Rialachán sin;

    for originators using the IRB Approach referred to in Article 143 of Regulation (EU) No 575/2013, the total committed amount per year shall not be higher than the one-year regulatory expected loss amounts on all underlying exposures for that year, calculated in accordance with Article 158 of that Regulation;

    Regulation (EU) 2021/557 of the European Parliament and of the Council of 31 March 2021 amending Regulation (EU) 2017/2402 laying down a general framework for securitisation and creating a specific framework for simple, transparent and standardised securitisation to help the recovery from the COVID-19 crisis

  6. #2486667

    I gcás ina ngeallann an tionscnóir barrachas an raoin difríochta shintéisigh, atá ar fáil mar fheabhas creidmheasa d’infheisteoirí, míniú achomair nach bhfuil an méid iomlán tiomanta in aghaidh na bliana níos airde, i gcás tionscnóirí a úsáideann an Cur Chuige Bunaithe ar Rátálacha Inmheánacha dá dtagraítear in Airteagal 143 de Rialachán (AE) Uimh. 575/2013, nach bhfuil sé níos airde ná méideanna an chaillteanais ionchasaigh rialála aon bhliana ar gach neamhchosaint fholuiteach don bhliain sin, arna ríomh i gcomhréir le hAirteagal 158 den Rialachán sin.

    Where the originator commits synthetic excess spread, which is available as credit enhancement for the investors, a concise explanation that, for originators using the Internal-Ratings-Based Approach referred to in Article 143 of Regulation (EU) No 575/2013, the total committed amount per year is not higher than the one-year regulatory expected loss amounts on all underlying exposures for that year, calculated in accordance with Article 158 of that Regulation.

    Commission Delegated Regulation (EU) 2022/1301 of 31 March 2022 amending the regulatory technical standards laid down in Delegated Regulation (EU) 2020/1226 as regards the information to be provided in accordance with the STS notification requirements for on-balance-sheet synthetic securitisations

  7. #3050556

    ag tabhairt dá haire, ag deireadh 2021, go raibh EUR 1452,1 milliún nó 91 % geallta ag Comhghnóthas IHI, arb ionann é agus EUR 1595,4 milliún de ranníocaíocht uasta an Aontais le haghaidh comhaontuithe deontais faoi Fís 2020 a síníodh; ag tabhairt dá haire gurbh é ba chúis leis sin nárbh fhéidir leis an nglao ar thograí in 2019 gach topaic a bhí beartaithe a chumhdach agus gur laghdaíodh buiséad an Aontais dá réir le cinneadh ón mbord rialaithe. ag tabhairt dá haire, as an méid geallta sin, go bhfuil thart ar EUR 616.8 milliún (nó 42,5 %) fós le híoc sna blianta amach romhainn; ag tabhairt dá haire, ina theannta sin, go raibh gealltanas dlíthiúil tugtha ag comhaltaí príobháideacha Chomhghnóthas IHI ranníocaíochtaí comhchineáil EUR 1520,7 milliún a sholáthar;

    Notes that, at the end of 2021, the IHI Joint Undertaking had committed EUR 1452,1 million or 91 %, of EUR 1595,4 million of the maximum Union contribution for signed Horizon 2020 grant agreements; notes that this was due to the fact that the 2019 call for proposals could not cover all topics planned and the Union budget had been reduced accordingly by decision of the governing board; notes that, of this committed amount, around EUR 616,8 million (or 42,5 %) remains to be paid in the coming years; notes, in addition, that the IHI Joint Undertaking’s private members had legally committed to provide in-kind contributions of EUR 1520,7 million;

    Resolution (EU) 2023/1960 of the European Parliament of 10 May 2023 with observations forming an integral part of the decision on discharge in respect of the implementation of the budget of the Innovative Health Initiative Joint Undertaking – IHI (before 30 November 2021 the Innovative Medicines Initiative 2 Joint Undertaking) for the financial year 2021